These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 19424643

  • 1. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
    Li J, Liu P, Mao H, Wanga A, Zhang X.
    Oncol Rep; 2009 Jun; 21(6):1605-10. PubMed ID: 19424643
    [Abstract] [Full Text] [Related]

  • 2. Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells.
    Zhou L, Liu P, Chen B, Wang Y, Wang X, Chiriva Internati M, Wachtel MS, Frezza EE.
    Anticancer Res; 2008 Jun; 28(2A):1119-27. PubMed ID: 18507063
    [Abstract] [Full Text] [Related]

  • 3. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L, Wang Z.
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [Abstract] [Full Text] [Related]

  • 4. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X, Wang S, Zhou J, Xing H, Xu G, Wang B, Chen G, Lu YP, Ma D.
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J, Valenti MR, De-Haven-Brandon AK, Vidot S, Eccles SA, Kaye SB, Richardson A.
    Clin Cancer Res; 2007 Dec 01; 13(23):7191-8. PubMed ID: 18056200
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.
    Dietrich CS, Greenberg VL, DeSimone CP, Modesitt SC, van Nagell JR, Craven R, Zimmer SG.
    Gynecol Oncol; 2010 Jan 01; 116(1):126-30. PubMed ID: 19875160
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
    Yang X, Xing H, Gao Q, Chen G, Lu Y, Wang S, Ma D.
    Gynecol Oncol; 2005 May 01; 97(2):413-21. PubMed ID: 15863139
    [Abstract] [Full Text] [Related]

  • 17. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
    Frankel A, Buckman R, Kerbel RS.
    Cancer Res; 1997 Jun 15; 57(12):2388-93. PubMed ID: 9192815
    [Abstract] [Full Text] [Related]

  • 18. [Impact of hypoxia on taxol-induced apoptosis in human ovarian cancer cell line A2780 and its mechanism].
    Huang L, Ao QL, Li F, Xing H, Lu YP, Ma D.
    Ai Zheng; 2005 Apr 15; 24(4):408-13. PubMed ID: 15820061
    [Abstract] [Full Text] [Related]

  • 19. Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells.
    Kim SH, Juhnn YS, Song YS.
    Ann N Y Acad Sci; 2007 Jan 15; 1095():82-9. PubMed ID: 17404021
    [Abstract] [Full Text] [Related]

  • 20. Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents.
    Coley HM, Shotton CF, Ajose-Adeogun A, Modjtahedi H, Thomas H.
    Biochem Pharmacol; 2006 Oct 16; 72(8):941-8. PubMed ID: 16934227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.